Kawarabayashi Takahiko, Okuno Keisuke, Niki Katsuyuki, Nakata Tsuyoshi, Matsumoto Mika, Otani Shinichiro, Wakami Satoki, Yoshihara Wataru, Taki Tomofumi, Kaneda Kozo, Nishiwaki Noboru, Tane Kazuyuki
Division of Cardiology, Tane General Hospital, Osaka, Japan.
Division of Plastic and Reconstructive Surgery, Tane General Hospital, Osaka, Japan.
J Cardiol Cases. 2015 Jun 25;12(5):139-142. doi: 10.1016/j.jccase.2015.05.014. eCollection 2015 Nov.
We present a rare case of cardiac malignant fibrous histiocytoma (MFH; undifferentiated pleomorphic sarcoma); to date, fewer than 100 cases of cardiac MFH have been reported. In this case, transthoracic echocardiography revealed cardiac tumors in the left atrium (LA) of a 53-year-old woman with a 3-month history of worsening dyspnea; the largest tumor was found to protrude through the mitral valve in diastole, causing stenosis. Three of the four tumors were resected during emergency surgery; however, the residual tumor extension into the left pulmonary vein could not be removed. Histological findings of the resected tumors, such as organized thrombus and myxomatous tissue changes, indicated that the tumors were benign. After 3 months, the patient underwent total resection for a small mass that developed on her right abdominal wall, which was revealed histologically to be MFH; additionally, the residual mass in the LA had enlarged progressively. After undergoing radiation therapy without further surgery, she died of cerebral bleeding 6 months after cardiac surgery. Postmortem examination revealed that the tumor in the LA was an MFH. Thus, cardiac MFH should be considered as a differential diagnosis for tumors on the posterior wall of the LA. < Primary cardiac malignant fibrous histiocytoma (MFH), which is easily mistaken for atrial myxoma, is a rare type of cardiac sarcoma. MFH occurs most commonly on the posterior wall of the left atrium (LA), and total resection is currently the only effective therapy; however, the prognosis is poor. Therefore, a high level of suspicion is required to facilitate early diagnosis. Cardiac MFH should be considered as a differential diagnosis for tumors on the posterior wall of the LA.>.
我们报告了一例罕见的心脏恶性纤维组织细胞瘤(MFH;未分化多形性肉瘤);迄今为止,报道的心脏MFH病例少于100例。在此病例中,经胸超声心动图显示一名53岁女性的左心房(LA)有心脏肿瘤,该女性有3个月的进行性呼吸困难病史;发现最大的肿瘤在舒张期穿过二尖瓣突出,导致狭窄。在急诊手术中切除了四个肿瘤中的三个;然而,残留肿瘤延伸至左肺静脉无法切除。切除肿瘤的组织学检查结果,如机化血栓和黏液瘤样组织改变,提示肿瘤为良性。3个月后,患者因右腹壁出现的一个小肿块接受了根治性切除,组织学检查显示为MFH;此外,左心房的残留肿块逐渐增大。在未进一步手术的情况下接受放射治疗后,她在心脏手术后6个月死于脑出血。尸检显示左心房的肿瘤为MFH。因此,心脏MFH应被视为左心房后壁肿瘤的鉴别诊断之一。<原发性心脏恶性纤维组织细胞瘤(MFH)容易被误诊为心房黏液瘤,是一种罕见的心脏肉瘤类型。MFH最常发生在左心房(LA)的后壁,目前根治性切除是唯一有效的治疗方法;然而,预后较差。因此,需要高度怀疑以促进早期诊断。心脏MFH应被视为左心房后壁肿瘤的鉴别诊断之一。>